Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
42
HSIC Quote, Financials, Valuation and Earnings
Last price:
$69.81
Seasonality move
:
4.99%
Day range:
$68.43 - $70.33
52-week range:
$63.67 - $82.63
Dividend yield:
0%
P/E ratio:
28.61x
P/S ratio:
0.72x
P/B ratio:
2.49x
Volume:
2.6M
Avg. volume:
1.8M
1-year change:
-4.88%
Market cap:
$8.7B
Revenue:
$12.3B
EPS (TTM):
$2.44
Analysts' Opinion
-
Consensus RatingHenry Schein has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Henry Schein has an estimated upside of 7.18% from its current price of $69.82.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $69.82.
Fair Value
-
According to the consensus of 0 analysts, Henry Schein has 7.18% upside to fair value with a price target of -- per share.
HSIC vs. S&P 500
-
Over the past 5 trading days, Henry Schein has underperformed the S&P 500 by -7% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Henry Schein does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Henry Schein has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Henry Schein reported revenues of $3.2B.
Earnings Growth
-
Henry Schein earnings have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Henry Schein reported earnings per share of $0.78.
Enterprise value:
12.7B
EV / Invested capital:
1.67x
Price / LTM sales:
0.72x
EV / EBIT:
24.15x
EV / Revenue:
1.02x
PEG ratio (5yr expected):
--
EV / Free cash flow:
30.17x
Price / Operating cash flow:
21.39x
Enterprise value / EBITDA:
15.58x
Gross Profit (TTM):
$3.9B
Return On Assets:
3.06%
Net Income Margin (TTM):
2.51%
Return On Equity:
6.21%
Return On Invested Capital:
4.24%
Operating Margin:
6.46%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $12.6B | $12.7B | $12.5B | $3.2B | $3.2B | |
| Gross Profit | $3.8B | $3.9B | $3.9B | $995M | $993M | |
| Operating Income | $890M | $828M | $599M | $211M | $205M | |
| EBITDA | $1.1B | $893M | $815M | $273M | $236M | |
| Diluted EPS | $4.60 | $3.38 | $2.44 | $1.05 | $0.78 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.9B | $3.9B | $4B | $4.1B | $4.1B | |
| Total Assets | $7.8B | $8.4B | $8.5B | $9.8B | $10.6B | |
| Current Liabilities | $2.6B | $2.3B | $2.1B | $2.1B | $2.9B | |
| Total Liabilities | $3.7B | $3.7B | $3.7B | $4.7B | $5.6B | |
| Total Equity | $4.1B | $4.7B | $4.8B | $5.1B | $5B | |
| Total Debt | $1.1B | $774.6M | $1B | $1.9B | $2.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $625M | $786M | $612M | $231M | $151M | |
| Cash From Investing | -$409M | -$873M | -$699M | -$468M | -$91M | |
| Cash From Financing | -$200M | $113M | $88M | $248M | -$41M | |
| Free Cash Flow | $495M | $587M | $421M | $181M | $107M | |
HSIC
Sector
Market Cap
$8.7B
$44.6M
Price % of 52-Week High
84.5%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
1.47%
-0.68%
1-Year Price Total Return
-4.88%
-29.09%
Beta (5-Year)
0.870
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$73.52
200-day SMA
Sell
Level
$70.84
Bollinger Bands (100)
Sell
Level
68.47 - 73.81
Chaikin Money Flow
Buy
Level
153.5M
20-day SMA
Sell
Level
$74.67
Relative Strength Index (RSI14)
Sell
Level
39.36
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-85.9446
50-day SMA
Sell
Level
$72.21
MACD (12, 26)
Sell
Level
-0.29
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
138.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.1626)
Buy
CA Score
(Annual)
Level (-0.2597)
Buy
Beneish M-Score
(Annual)
Level (-2.2728)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.6262)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
Stock Forecast FAQ
In the current month, HSIC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HSIC average analyst price target in the past 3 months is --.
-
Where Will Henry Schein Stock Be In 1 Year?
According to analysts, the consensus estimate is that Henry Schein share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Henry Schein?
Analysts are divided on their view about Henry Schein share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Henry Schein is a Sell and believe this share price will drop from its current level to --.
-
What Is Henry Schein's Price Target?
The price target for Henry Schein over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HSIC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Henry Schein is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HSIC?
You can purchase shares of Henry Schein via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Henry Schein shares.
-
What Is The Henry Schein Share Price Today?
Henry Schein was last trading at $69.81 per share. This represents the most recent stock quote for Henry Schein. Yesterday, Henry Schein closed at $69.82 per share.
-
How To Buy Henry Schein Stock Online?
In order to purchase Henry Schein stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
